Mammography is a technically demanding modality. The technologist must include as much breast tissue as possible, immobilize it with appropriate compression, and minimize folds, motion, and superimposed body parts while communicating with the patient. Positioning deficiencies can exclude tissue or require a technical repeat; they should not be confused with a clinical recall, which is additional evaluation of an imaging or clinical finding.
The postprimary ARRT Mammography examination includes positioning, but ARRT certification and legal authority to perform mammography are different questions. In the United States, personnel must meet federal MQSA qualifications plus any applicable state licensing requirements; the ACR accredits facilities and does not certify technologists. This guide reviews routine CC and MLO projections, implant-displaced views, compression, common positioning errors, and the distinct roles of MQSA and ACR guidance. Local protocols and the mammography unit's instructions remain controlling.
Screening mammography uses low-dose x-rays to detect breast cancer before symptoms develop. The ACR recommends annual screening beginning at age 40 for average-risk women; other organizations use different intervals, so patient care follows the applicable guideline and individualized risk assessment. Compression can improve sharpness, reduce overlap and scatter, and usually reduce the exposure needed for a given breast, but no universal percentage dose reduction applies to every patient or system.
Dedicated mammography units are fundamentally different from general radiography equipment. Understanding the unique hardware is essential for proper positioning.
Dedicated systems generate a breast-optimized x-ray spectrum. Depending on the platform and acquisition mode, targets may be molybdenum, rhodium, or tungsten, with filters such as molybdenum, rhodium, silver, or aluminum. The AEC selects technique within the manufacturer's available range rather than a universal 25–35 kVp rule. Focal-spot size and the fixed source-to-image distance (often roughly 60–70 cm) are also manufacturer-specific; they are not positioning parameters for the technologist to change.
The compression paddle immobilizes and thins the breast. Paddle design, permitted tilt or flex, and use of standard, spot, or magnification paddles are system-specific. Before exposure, the technologist verifies that the correct paddle is secure and that compression is distributed appropriately, with no pinched skin or unintended body part in the field. Compression should be sufficient for a stable, diagnostic image without unnecessary or intolerable pain.
Modern mammography uses full-field digital mammography (FFDM) and/or digital breast tomosynthesis (DBT). Detector sampling and acquisition geometry vary by model, and DBT may use an acquired or synthetic 2D image according to protocol. Technologists perform the manufacturer- and facility-specified detector and artifact checks; detector contamination, calibration problems, or other artifacts can obscure tissue or resemble findings.
| Parameter | Mammography | General Radiography |
|---|---|---|
| Target/Filter | System/mode-specific: Mo, Rh, or W targets; Mo, Rh, Ag, Al, or other approved filters | Commonly W target with added filtration; system-specific |
| Technique | Breast-optimized, usually selected by AEC | Exam- and anatomy-specific |
| SID | Fixed by manufacturer; commonly about 60–70 cm | Selected for the projection/equipment |
| Focal Spot | Small; manufacturer- and mode-specific | Tube/system-specific |
| Detector Sampling | High-resolution, system-specific | System-specific |
| Compression | Dedicated breast compression paddle | Immobilization only when clinically needed |
The CC view is one of the two standard screening projections. It images the breast from superior to inferior, providing a mediolateral perspective of the breast parenchyma. The CC view is particularly valuable for visualizing the medial breast tissue and the retroareolar region — areas that can be poorly visualized on the MLO view.
Failure to include posterior breast tissue can leave anatomy unevaluated. The posterior nipple line (PNL) is measured on each view from the nipple (or skin line if the nipple is rolled) posteriorly at 90° to the pectoralis/chest-wall edge. The CC PNL length should be within 1 cm of the MLO PNL length. This is a comparison of two measured lengths—not a requirement that tissue lie “within 1 cm of the posterior edge”—and it is assessed with direct visualization of posterior tissue.
The MLO complements the CC view by imaging the breast along the pectoral-muscle plane and generally including more posterior and superior-lateral tissue than a true lateral view. It should include the axillary tail when anatomy permits, but neither one projection nor the axillary tail should be described as the sole or universally “most important” site for cancer detection.
For a well-positioned MLO, the pectoralis should reach the PNL or below, with a convex anterior edge, while posterior tissue and an open IMF are also shown. This is an image-quality criterion, not proof that every patient can meet an identical appearance. If anatomy, mobility, surgery, or pain limits the view, optimize safely, obtain additional imaging only under protocol/radiologist direction, and document the limitation rather than automatically repeating solely to satisfy one visual sign.
Compression is a major technical factor in mammography and works together with positioning, AEC, detector performance, and motion control:
Compression generally reduces breast thickness and the exposure needed for that view. The size of the dose change varies with breast composition, AEC response, technique, and system; a fixed “50%” reduction should not be promised.
Compression spreads the breast parenchyma into a thinner, more uniform layer, reducing the chance that a small lesion is hidden by overlapping normal tissue.
Compression reduces motion by immobilizing the breast and reduces geometric blurring by bringing tissue closer to the detector.
A thinner breast produces less scatter, improving contrast and reducing the fog that degrades image quality.
There is no universal target patient thickness or single force value. The often-cited 4.2-cm thickness is the MQSA “standard breast” used for phantom dosimetry, not a goal for compressing every patient. Clinical compression should immobilize the breast, separate tissue, and produce a reproducible image without unnecessary pain, following the unit's instructions and facility protocol. The technologist should:
Explain the sequence and purpose of compression, agree on a stop signal, lower the paddle gradually, watch for pinched skin, and keep the patient's hands clear of moving equipment unless the manufacturer's instructions and facility protocol explicitly permit otherwise. Coach normal breathing during setup, then stillness and a brief respiratory pause for exposure. Never continue solely to reach a preset thickness or force when the patient reports intolerable pain.
Saline- and silicone-filled implants are radiopaque enough to obscure variable amounts of breast tissue on implant-in-field views. The implant-displaced (ID) view, also called the Eklund technique, brings more native tissue anterior to the implant for evaluation; it does not guarantee visualization of a fixed percentage of tissue and does not replace the implant-in-field views when those views can be obtained.
Recognition and correction of positioning errors is essential for producing diagnostic-quality mammograms. The following table summarizes the most frequent errors and their corrections:
| Error | Cause | Correction |
|---|---|---|
| Medial tissue excluded on CC | Breast not pulled forward from chest wall | Palpate medial edge, ensure full medial inclusion |
| Pectoralis does not approach the PNL on MLO | Receptor angle/body alignment, shoulder tension, or posterior tissue inclusion may be suboptimal | Reassess receptor angle and patient proximity; relax the shoulder and bring posterior breast tissue onto the receptor without forcing the arm |
| Nipple not in profile | Breast rotated on detector | Center nipple, ensure perpendicular orientation |
| Inframammary fold obscured | Breast pushed too high on detector | Lower breast, ensure IMF is open and visible |
| Concave anterior pectoral border | Inadequate pectoralis inclusion/positioning | Reassess MLO angle, patient proximity, shoulder relaxation, and posterior tissue inclusion |
| Skin folds superimposing tissue | Breast bunched during compression | Smooth skin folds before compressing |
| Inadequate compression or motion | Pain, slipping tissue, insufficient immobilization, or incorrect paddle use | Release and reassess; reposition, use the paddle per manufacturer instructions, and apply gradual patient-tolerated compression |
These roles must not be conflated. Under the federal Mammography Quality Standards Act (MQSA), U.S. mammography facilities must be accredited by an FDA-approved accreditation body, certified by FDA or an approved state certifier, and inspected annually. The American College of Radiology (ACR) operates one FDA-approved accreditation program and publishes practice parameters and educational positioning criteria; ACR is not the sole accreditor and does not license technologists.
Annual on-site inspection is an MQSA process, distinct from an accreditation body's testing cycle and the medical physicist's annual survey. Technologist QC test names and frequencies depend on the FDA-approved or manufacturer-specific QC program; a phantom image is not universally a daily digital-mammography task. Technologists should perform assigned QC on schedule, review repeats/rejects and image-quality feedback, document failures, and complete corrective action before clinical use when required. For general QC concepts, see radiography quality control.
Mammography uses low-dose ionizing radiation, but dose quantities must not be mixed. Mean glandular dose is absorbed breast dose in mGy; effective dose is a risk-weighted whole-body quantity in mSv. MQSA limits the average glandular dose for a single CC exposure of the 4.2-cm standard breast phantom to 3.0 mGy (0.3 rad); this is an equipment/QC ceiling, not a typical patient dose or a whole-exam limit. ACR/RSNA's RadiologyInfo lists a representative effective dose of about 0.28 mSv for a screening digital mammogram (bilateral CC+MLO), about 34 days of U.S. natural background radiation. Actual patient dose varies with breast thickness/composition, views, repeats, and 2D/DBT protocol.
For more on radiation protection principles, see our comprehensive guide on radiation safety for radiologic technologists. And for a deeper understanding of how exposure factors interact, review our article on kVp and mAs exposure factors.
Screening mammography is for an asymptomatic patient. A new lump, focal persistent pain, clinically suspicious nipple discharge, skin/nipple retraction, or another concerning sign should be communicated before positioning and managed through the facility's diagnostic pathway rather than treated as routine screening. Diagnostic mammography is tailored to the clinical or imaging concern and may be accompanied by targeted ultrasound or other imaging. The technologist should not independently add or omit diagnostic views outside protocol or radiologist direction.
Pregnancy is not an absolute contraindication to mammography. Current ACR guidance states that properly performed mammography is considered safe during pregnancy and that fetal scatter is negligible. Do not delay clinically indicated breast evaluation because of pregnancy: ultrasound is usually the initial test for a focal symptom in a pregnant patient, with diagnostic mammography added when appropriate for age and clinical scenario. ACR also supports age- and risk-appropriate screening during pregnancy. Confirm pregnancy status under facility policy, inform the radiologist/referrer when relevant, optimize the examination, and do not promise that abdominal shielding is required or that it replaces justification and optimization. Mammography is also safe during lactation; feeding or pumping shortly before imaging may reduce breast fullness and improve comfort, but local instructions apply.
Heterogeneously or extremely dense tissue can mask cancer on mammography, and dense tissue is itself a risk factor. Compression and positioning should be optimized for every patient, but compression cannot eliminate density-related masking. Supplemental ultrasound, MRI, contrast-enhanced mammography, or no additional test may be appropriate depending on overall risk, density, prior imaging, availability, and patient preference; density alone does not authorize the technologist to select a supplemental test.
Patients with shoulder arthritis, limited mobility, wheelchair use, or post-surgical restrictions may not be able to raise an arm or stand. Accommodations can include seated positioning, safe transfer aids, adjusted receptor angle/height, and trained assistance that does not force a restricted joint. Document positioning limitations and their impact, and obtain radiologist/protocol guidance if routine views cannot be completed safely.
High-risk screening is individualized. ACR recommends risk assessment by age 25 and MRI surveillance starting around ages 25–30 for many people with genetics-based risk or a calculated lifetime risk of at least 20%; annual mammography may start between ages 25 and 40 depending on the risk type. MRI is generally supplemental, not an automatic replacement for mammography. Follow the ordering clinician, radiologist, and current risk-based protocol rather than applying a single “under 40” rule.
This educational overview distinguishes enforceable MQSA requirements from ACR practice parameters and quality-improvement criteria. Primary references: 21 CFR Part 900 (MQSA regulations); FDA MQSA FAQ; ACR Practice Parameter for Screening and Diagnostic Mammography; ACR–AAPM–SIIM image-quality parameter; ACR positioning review guidelines; ACR Breast Imaging During Pregnancy; ACR–SPR pregnancy radiation parameter; FDA breast-implant rupture guidance; FDA implant adverse-event review; and ACR/RSNA representative dose table. Exact positioning maneuvers and QC frequencies remain equipment- and facility-specific.
Try these ARRT-style multiple choice questions based on this article. Click an option to check your answer — correct answers turn green, wrong ones turn red.